Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nodular Sclerosis Classical Hodgkin Lymphoma”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Study completedNCT00070304
What this trial is testing

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 33
Testing effectiveness (Phase 2)Study completedNCT00381940
What this trial is testing

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+17 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT00678327
What this trial is testing

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Who this might be right for
Lymphoma
University College, London 1,202
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202
What this trial is testing

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more
City of Hope Medical Center 155
Testing effectiveness (Phase 2)Study completedNCT00369681
What this trial is testing

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Study completedNCT00398554
What this trial is testing

Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Christine Mauz-Körholz 16
Testing effectiveness (Phase 2)Study completedNCT00255723
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 98
Large-scale testing (Phase 3)Study completedNCT00302003
What this trial is testing

Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma

Who this might be right for
Childhood Favorable Prognosis Hodgkin LymphomaChildhood Lymphocyte Depletion Hodgkin LymphomaChildhood Mixed Cellularity Hodgkin Lymphoma+3 more
Children's Oncology Group 287
Large-scale testing (Phase 3)Study completedNCT00433459
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Christine Mauz-Körholz 2,134
Testing effectiveness (Phase 2)Study completedNCT00004010
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease

Who this might be right for
Lymphoma
Children's Oncology Group 99
Large-scale testing (Phase 3)Active Not RecruitingNCT03907488
What this trial is testing

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Lymphocyte-Depleted Classic Hodgkin LymphomaAnn Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma+7 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00025259
What this trial is testing

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

Who this might be right for
Childhood Lymphocyte-Depleted Classical Hodgkin LymphomaChildhood Mixed Cellularity Classical Hodgkin LymphomaChildhood Nodular Lymphocyte Predominant Hodgkin Lymphoma+5 more
Children's Oncology Group 1,734
Testing effectiveness (Phase 2)Study completedNCT01535924
What this trial is testing

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+3 more
Beth Christian 26
Testing effectiveness (Phase 2)Study completedNCT00666484
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

Who this might be right for
LymphomaNeurotoxicity
University College, London 47
Testing effectiveness (Phase 2)Ended earlyNCT00225173
What this trial is testing

Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease

Who this might be right for
Hodgkin Disease
Stanford University 45
Testing effectiveness (Phase 2)UnknownNCT03077828
What this trial is testing

Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Lymphocyte-Rich Classical Hodgkin LymphomaRecurrent Lymphocyte-Depleted Classical Hodgkin LymphomaRecurrent Mixed Cellularity Classical Hodgkin Lymphoma+4 more
Northwestern University 43
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00002461
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Montefiore Medical Center 35
Early research (Phase 1)Study completedNCT00439361
What this trial is testing

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaLymphoma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)UnknownNCT03226249
What this trial is testing

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaLymphocyte-Depleted Classical Hodgkin LymphomaLymphocyte-Rich Classical Hodgkin Lymphoma+2 more
Northwestern University 30
Load More Results
994